Revenue
2015
2016
2017
2019
2020
2021
2022
2023
2024
2025
KALA BIO, Inc. (KALA)
Price$0.5073Cached quote
Net income
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2015
2016
2017
2018
2019
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $3.9M | $11.2M | $6.4M | $6.1M | — | $0 | $0 | $45,000 |
| Research & development | $18.8M | $22.1M | $18.6M | $17.7M | $11.5M | $18.4M | $27.3M | $29.3M | $29.0M | $25.0M | $11.4M |
| Operating expenses | $39.2M | $41.0M | $39.7M | $85.6M | $141.5M | $102.6M | $94.3M | $64.7M | $39.9M | $32.7M | $16.0M |
| Operating income | −$39.2M | −$41.0M | −$39.7M | −$81.7M | −$130.2M | −$96.2M | −$88.2M | −$64.7M | −$39.9M | −$32.7M | −$15.9M |
| Operating margin | — | — | — | −2,099.33% | −1,158.76% | −1,512.59% | −1,452.49% | — | — | — | −35,435.56% |
| EBITDA | −$38.8M | −$40.7M | −$39.4M | −$81.2M | −$129.3M | −$95.3M | −$87.4M | −$64.4M | −$39.6M | −$32.4M | −$15.6M |
| EBITDA margin | — | — | — | −2,085.53% | −1,150.09% | −1,498.26% | −1,438.61% | — | — | — | −34,702.22% |
| Net income | −$27.0M | −$38.5M | −$42.2M | −$44.8M | −$142.6M | −$104.3M | −$94.3M | −$66.7M | −$42.2M | −$33.2M | −$16.7M |
| Net profit margin | — | — | — | −1,151.64% | −1,268.73% | −1,639.85% | −1,553.29% | — | — | — | −37,071.11% |
| Basic EPSper basic share | -$165.50 | -$507.50 | -$867.50 | -$1,474.00 | -$5,416.00 | -$4,975.00 | -$6,900.00 | -$6,225.00 | -$9,275.00 | -$70,175.00 | -$37,225.00 |
| Diluted EPSper diluted share | -$165.50 | -$507.50 | -$867.50 | -$1,474.00 | -$5,416.00 | -$4,975.00 | -$6,900.00 | -$6,225.00 | -$9,275.00 | -$70,175.00 | -$37,225.00 |
Owners
Reported shareholders
≈8.38%of listed shares
OXFORD FINANCE LLC1.62M shares · Nov 25, 2025
View holders
| Holder | % owned |
|---|---|
OXFORD FINANCE LLC | ≈8.38%1.62M shares |
BAKER JULIAN / BAKER BROS. ADVISORS LP / Baker Bros. Advisors (GP) LLC / BAKER FELIX | ≈2.44%471.49K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 1.14%220.62K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.75%145.15K shares |
Iwicki Mark T | ≈0.54%103.54K shares |
VANGUARD FIDUCIARY TRUST CO | 0.52%101.4K shares |
BlackRock, Inc. | 0.37%71.54K shares |
Kharabi Darius | ≈0.22%41.76K shares |
NORTHERN TRUST CORP | 0.22%41.61K shares |
Brazzell Romulus K | ≈0.19%35.95K shares |
Bazemore Todd | ≈0.19%35.93K shares |
Reumuth Mary | ≈0.15%28.91K shares |
KOVEN ANDREW I | ≈0.09%16.97K shares |
Rosen Howard B | ≈0.09%16.5K shares |
PERRY GREGORY D | ≈0.07%13.34K shares |
Qube Research & Technologies Ltd | 0.06%11.07K shares |
GOLDMAN SACHS GROUP INC | 0.06%10.92K shares |
Myers C. Daniel | ≈0.05%10.37K shares |
Farid Marjan | ≈0.05%10.24K shares |
UBS Group AG | 0.05%9.06K shares |
Percentages use 19.34M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 3 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Oct 23, 2025Form 4 | Reumuth MaryCHIEF FINANCIAL OFFICER | SellCommon Stock | 967 | $0.82 | $792.94 | 28.9K |
| Oct 23, 2025Form 4 | Iwicki Mark TDirector | SellCommon Stock | 154.9K | $0.81 | $125.5K | 103.5K |
| Oct 22, 2025Form 4 | Kharabi DariusCHIEF BUSINESS OFFICER | SellCommon Stock | 20.8K | $0.83 | $17.3K | 41.8K |
| Oct 22, 2025Form 4 | Reumuth MaryCHIEF FINANCIAL OFFICER | SellCommon Stock | 32.2K | $0.83 | $26.8K | 29.9K |
| Oct 22, 2025Form 4 | Bazemore ToddDirector | SellCommon Stock | 47.8K | $0.83 | $39.6K | 35.9K |